---
document_datetime: 2025-12-02 06:50:11
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/ablavar.html
document_name: ablavar.html
version: success
processing_time: 0.1189925
conversion_datetime: 2025-12-28 00:25:14.236771
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Ablavar (previously Vasovist)

[RSS](/en/individual-human-medicine.xml/65627)

##### Withdrawn

This medicine's authorisation has been withdrawn

gadofosveset trisodium Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Ablavar](#more-information-on-ablavar-1031)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 3 October 2005 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Vasovist (gadofosveset) for contrast-enhanced magnetic resonance angiography (CE-MRA) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease. The name of the medicinal product was changed to Ablavar on 10 January 2011. The marketing authorisation holder (MAH) responsible for Ablavar was TMC Pharma Services Ltd.

The European Commission was notified by a letter dated 13 September 2011 of the MAH's decision to voluntarily withdraw the marketing authorisation as of the Commission Decision date for Ablavar for commercial reasons. Ablavar was not marketed in any European country. On 18 October 2011 the European Commission issued a decision to withdraw the marketing authorisation for Ablavar.

Pursuant to this decision the European Public Assessment Report for Ablavar is updated to reflect that the marketing authorisation is no longer valid.

Ablavar: EPAR - Summary for the public

English (EN) (288.17 KB - PDF)

**First published:** 29/07/2009

**Last updated:** 10/02/2011

[View](/en/documents/overview/ablavar-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-769)

български (BG) (381.04 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/bg/documents/overview/ablavar-epar-summary-public_bg.pdf)

español (ES) (287.87 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/es/documents/overview/ablavar-epar-summary-public_es.pdf)

čeština (CS) (406.77 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/cs/documents/overview/ablavar-epar-summary-public_cs.pdf)

dansk (DA) (349.76 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/da/documents/overview/ablavar-epar-summary-public_da.pdf)

Deutsch (DE) (352.48 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/de/documents/overview/ablavar-epar-summary-public_de.pdf)

eesti keel (ET) (345.06 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/et/documents/overview/ablavar-epar-summary-public_et.pdf)

ελληνικά (EL) (446.47 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/el/documents/overview/ablavar-epar-summary-public_el.pdf)

français (FR) (289.45 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/fr/documents/overview/ablavar-epar-summary-public_fr.pdf)

italiano (IT) (351.53 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/it/documents/overview/ablavar-epar-summary-public_it.pdf)

latviešu valoda (LV) (412.83 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/lv/documents/overview/ablavar-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (373.05 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/lt/documents/overview/ablavar-epar-summary-public_lt.pdf)

magyar (HU) (401.9 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/hu/documents/overview/ablavar-epar-summary-public_hu.pdf)

Malti (MT) (408.15 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/mt/documents/overview/ablavar-epar-summary-public_mt.pdf)

Nederlands (NL) (348.38 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/nl/documents/overview/ablavar-epar-summary-public_nl.pdf)

polski (PL) (410.26 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/pl/documents/overview/ablavar-epar-summary-public_pl.pdf)

português (PT) (287.7 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/pt/documents/overview/ablavar-epar-summary-public_pt.pdf)

română (RO) (316.56 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/ro/documents/overview/ablavar-epar-summary-public_ro.pdf)

slovenčina (SK) (405.64 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/sk/documents/overview/ablavar-epar-summary-public_sk.pdf)

slovenščina (SL) (400.68 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/sl/documents/overview/ablavar-epar-summary-public_sl.pdf)

Suomi (FI) (76.15 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/fi/documents/overview/ablavar-epar-summary-public_fi.pdf)

svenska (SV) (347.91 KB - PDF)

**First published:**

29/07/2009

**Last updated:**

10/02/2011

[View](/sv/documents/overview/ablavar-epar-summary-public_sv.pdf)

## Product information

Ablavar: EPAR - Product Information

English (EN) (464.64 KB - PDF)

**First published:** 30/07/2009

**Last updated:** 16/09/2011

[View](/en/documents/product-information/ablavar-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-168)

български (BG) (1.15 MB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/bg/documents/product-information/ablavar-epar-product-information_bg.pdf)

español (ES) (462.49 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/es/documents/product-information/ablavar-epar-product-information_es.pdf)

čeština (CS) (874.72 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/cs/documents/product-information/ablavar-epar-product-information_cs.pdf)

dansk (DA) (453.47 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/da/documents/product-information/ablavar-epar-product-information_da.pdf)

Deutsch (DE) (789.25 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/de/documents/product-information/ablavar-epar-product-information_de.pdf)

eesti keel (ET) (449.07 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/et/documents/product-information/ablavar-epar-product-information_et.pdf)

ελληνικά (EL) (1.17 MB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/el/documents/product-information/ablavar-epar-product-information_el.pdf)

français (FR) (482.84 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/fr/documents/product-information/ablavar-epar-product-information_fr.pdf)

íslenska (IS) (471.69 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/is/documents/product-information/ablavar-epar-product-information_is.pdf)

italiano (IT) (460.53 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/it/documents/product-information/ablavar-epar-product-information_it.pdf)

latviešu valoda (LV) (911.1 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/lv/documents/product-information/ablavar-epar-product-information_lv.pdf)

lietuvių kalba (LT) (628.25 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/lt/documents/product-information/ablavar-epar-product-information_lt.pdf)

magyar (HU) (1.14 MB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/hu/documents/product-information/ablavar-epar-product-information_hu.pdf)

Malti (MT) (917.79 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/mt/documents/product-information/ablavar-epar-product-information_mt.pdf)

Nederlands (NL) (494.7 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/nl/documents/product-information/ablavar-epar-product-information_nl.pdf)

norsk (NO) (463.27 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/no/documents/product-information/ablavar-epar-product-information_no.pdf)

polski (PL) (907.33 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/pl/documents/product-information/ablavar-epar-product-information_pl.pdf)

português (PT) (465.71 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/pt/documents/product-information/ablavar-epar-product-information_pt.pdf)

română (RO) (624.14 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/ro/documents/product-information/ablavar-epar-product-information_ro.pdf)

slovenčina (SK) (869.9 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/sk/documents/product-information/ablavar-epar-product-information_sk.pdf)

slovenščina (SL) (805.95 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/sl/documents/product-information/ablavar-epar-product-information_sl.pdf)

Suomi (FI) (767.16 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/fi/documents/product-information/ablavar-epar-product-information_fi.pdf)

svenska (SV) (458.85 KB - PDF)

**First published:**

30/07/2009

**Last updated:**

16/09/2011

[View](/sv/documents/product-information/ablavar-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0020 15/05/2011

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Ablavar : EPAR - All Authorised presentations

English (EN) (458.35 KB - PDF)

**First published:** 04/11/2005

**Last updated:** 10/02/2011

[View](/en/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_en.pdf)

[Other languages (23)](#file-language-dropdown-702)

български (BG) (320.82 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/bg/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_bg.pdf)

español (ES) (247.26 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/es/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_es.pdf)

čeština (CS) (321.05 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/cs/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (248.48 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/da/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (248.4 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/de/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (459.36 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/et/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (324.22 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/el/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_el.pdf)

français (FR) (244.96 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/fr/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_fr.pdf)

íslenska (IS) (237.03 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/is/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_is.pdf)

italiano (IT) (246.86 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/it/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (325.42 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/lv/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (525.32 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/lt/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (498.89 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/hu/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (322.85 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/mt/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (246.7 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/nl/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (248.87 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/no/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_no.pdf)

polski (PL) (325.48 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/pl/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_pl.pdf)

português (PT) (248.48 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/pt/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_pt.pdf)

română (RO) (310.55 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/ro/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (324.12 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/sk/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (273.98 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/sl/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (247.29 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/fi/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (248.56 KB - PDF)

**First published:**

04/11/2005

**Last updated:**

10/02/2011

[View](/sv/documents/all-authorised-presentations/ablavar-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Ablavar (previously Vasovist) Active substance gadofosveset trisodium International non-proprietary name (INN) or common name gadofosveset trisodium Therapeutic area (MeSH) Magnetic Resonance Angiography Anatomical therapeutic chemical (ATC) code V08CA

### Pharmacotherapeutic group

Contrast media

### Therapeutic indication

This medicinal product is for diagnostic use only.

Ablavar is indicated for contrast-enhanced magnetic resonance angiography (CE-MRA) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease.

## Authorisation details

EMA product number EMEA/H/C/000601 Marketing authorisation holder

TMC Pharma Services Ltd.

Finchampstead

Marketing authorisation issued 03/10/2005 Withdrawal of marketing authorisation 18/10/2011 Revision 10

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Ablavar : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (312.69 KB - PDF)

**First published:** 30/07/2009

**Last updated:** 16/09/2011

[View](/en/documents/procedural-steps-after/ablavar-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Vasovist-H-C-601-A-20-15: EPAR - Assessment Report - Variation

Adopted

Reference Number: EMA/452190/2010

English (EN) (420.55 KB - PDF)

**First published:** 25/11/2010

**Last updated:** 25/11/2010

[View](/en/documents/variation-report/vasovist-h-c-601-20-15-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Vasovist : EPAR - Procedural steps taken before authorisation

English (EN) (295.68 KB - PDF)

**First published:** 04/11/2005

**Last updated:** 04/11/2005

[View](/en/documents/procedural-steps/vasovist-epar-procedural-steps-taken-authorisation_en.pdf)

Vasovist : EPAR - Scientific Discussion

English (EN) (655.58 KB - PDF)

**First published:** 04/11/2005

**Last updated:** 04/11/2005

[View](/en/documents/scientific-discussion/vasovist-epar-scientific-discussion_en.pdf)

#### More information on Ablavar

Questions and answers on the review of gadolinium-containing contrast agents

Adopted

Reference Number: EMEA/727399/2009

English (EN) (48.93 KB - PDF)

**First published:** 21/11/2009

**Last updated:** 02/09/2010

[View](/en/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_en.pdf)

[Other languages (21)](#file-language-dropdown-26)

български (BG) (242.44 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/bg/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_bg.pdf)

español (ES) (113.18 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/es/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_es.pdf)

čeština (CS) (192.16 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/cs/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_cs.pdf)

dansk (DA) (49.95 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/da/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_da.pdf)

Deutsch (DE) (50.93 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/de/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_de.pdf)

eesti keel (ET) (49.65 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/et/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_et.pdf)

ελληνικά (EL) (237.73 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/el/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_el.pdf)

français (FR) (51.25 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/fr/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_fr.pdf)

italiano (IT) (50.72 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/it/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_it.pdf)

latviešu valoda (LV) (193.87 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/lv/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_lv.pdf)

lietuvių kalba (LT) (191.27 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/lt/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_lt.pdf)

magyar (HU) (96.49 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/hu/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_hu.pdf)

Malti (MT) (220.89 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/mt/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_mt.pdf)

Nederlands (NL) (50.88 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/nl/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_nl.pdf)

polski (PL) (136.04 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/pl/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_pl.pdf)

português (PT) (111.38 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/pt/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_pt.pdf)

română (RO) (189.91 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/ro/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_ro.pdf)

slovenčina (SK) (189.71 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/sk/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_sk.pdf)

slovenščina (SL) (184.89 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/sl/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_sl.pdf)

Suomi (FI) (48.64 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/fi/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_fi.pdf)

svenska (SV) (49.62 KB - PDF)

**First published:**

21/11/2009

**Last updated:**

02/09/2010

[View](/sv/documents/referral/questions-and-answers-review-gadolinium-containing-contrast-agents_sv.pdf)

**This page was last updated on** 14/11/2011

## Share this page

[Back to top](#main-content)